Why the study?
Does amiodarone reduce the dispersion of atrial fibrillation cycle length in patients with atrial fibrillation?
Does amiodarone reduce the dispersion of atrial fibrillation cycle length in patients with atrial fibrillation?
Amiodarone reduces the dispersion of atrial fibrillation cycle length, providing a potential mechanistic explanation for its beneficial effects in AF.
Amiodarone-associated reduction in AFCL dispersion should not change practice; leaves open mechanistic role in AF.
Amiodarone causes a reduction in the dispersion of AFCL. This action may be relevant to the beneficial effects of amiodarone in patients with AF.
No takes yet. Share an insight, caveat, or question.
Fynn et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: